This is an article from a colleague, Ron Whitmont MD, a homeopathic physician who has been studying the microbiome for some time. There is a lot of useful information and it is well-documented. He has given permission for it to be shared, but NOT EDITED, OR SELECTIVELY CUT AND PASTED IN ANY FORM WHATSOEVER. I ask you to please respect his wishes, as I have in posting it on my site.

The Novel 2019 Coronavirus

By now, nearly everyone on the planet is aware of the outbreak of the 2019 novel coronavirus (COVID-19) that emerged in Wuhan, China (one of the first Cities to launch 5G wireless technology ) causing multiple cases of pneumonia, adult respiratory distress syndrome (ARDS) and a significant number of deaths, mostly in elderly men. There is no conventionally recognized effective preventative treatment or cure for COVID-19, though homeopaths have successfully treated similar outbreaks of epidemic infectious disease for more than two centuries.

A number of cases of COVID-19 have already reached the US and 9 people have already died; some of these were the result of direct contacts with China, but others are considered “community acquired” since they had no known connection to the original source. Media outlets are busy fueling a frenzy of stories and editorials. The federal government considers these warnings part of a “democratic weaponization” of the news media. In the midst of all this confusion, with global stock markets tumbling, how does anyone make sense of what is actually happening? What is actually happening?

It’s natural to wonder if this blitz of fearmongering reflects a reliable threat, or if it is simply an overreaction to a completely normal and natural process. Is there a global pandemic, a medical Armageddon, or is COVID-19 simply following predictable patterns of viral dissemination? The answer may be a little bit of both scenarios: for most people, the media frenzy is part of an overblown overreaction to a largely benign process; but for some, principally those who rely heavily on conventional medicines and vaccines to protect their health, this epidemic does represent a very real (albeit a man-made) and dangerous threat. A brief analysis of the overall situation might explain why.

So far, the majority (at least 82%) of known cases of COVID-19 infection (including children) have either extremely mild symptoms, similar to the common cold, or no symptoms at all. The remaining 18% have more severe symptoms and a very small percentage have developed pneumonia and respiratory distress. Somewhere around 3% have died from this infection. The majority of deaths were elderly men being treated for pre-existing chronic medical conditions, including diabetes, kidney, lung, heart and liver disease.

In other words, most people who are exposed to the COVID-19 virus will only develop mild upper respiratory symptoms similar to the “common cold.” A small number of people, predominantly those who receive treatment for an underlying preexisting medical condition, are at higher risk for developing a more severe illness, complications and death.

Since the majority (60%) of the US population suffers from some form of chronic medical illness, and 40% live with more than one chronic medical condition, a significant number of Americans are at heightened risk of complications from COVID-19. Corona viruses are similar to other viruses, like influenza or the “common cold” viruses, since they all tend to adversely affect those with chronic illness. What isn’t clear is if the increased risk of complications from these viral infections is due to the underlying chronic medical condition itself, or to the concomitant use of medicines that suppress the immune inflammatory response and increase the odds of complications. Much more background information from individual cases would be necessary to determine if it is the disease, the medical treatment, or some combination of both that increases the rate of fatal outcome from viral infections including COVID-19.

There have been a few deaths from COVID-19 in otherwise “healthy” individuals, but no helpful details have been provided about these cases. It would be useful to know what medical therapies (steroids, antibiotics, antivirals), antipyretics (Tylenol, aspirin, ibuprofen), anti-inflammatory or over-the-counter medicines (decongestants, antihistamines) were used by these “healthy” individuals who died, and not used by those who only had minor symptoms. Many of these drugs suppress the immune inflammatory response, temporarily ameliorating symptoms, but simultaneously weakening innate immune defense mechanisms that protect the body against invasive infections. In these otherwise “healthy” individuals, something interfered with their ability to withstand infection, but what it was, was not revealed. Obtaining this type of background information might be extremely helpful in understanding the factors that contribute to mortality risk from COVID-19.

During the great influenza epidemic of 1918, the global pandemic that killed millions worldwide, there were similar factors involved. In that pandemic aspirin (which was first made available for over the counter use in 1915) was, for the first time in history, strongly and widely recommended to prevent and treat influenza. There is now considerable anecdotal and preclinical evidence implicating the use of aspirin in the grave consequences that resulted in otherwise “young and healthy” individuals who precipitously died from this virus. Modern-day physicians now understand that aspirin is contraindicated in all viral infections precisely because of its’ immune and neurological complications.

This information has not stopped most conventional physicians from recommending aspirin for the primary prevention of cardiovascular disease in older men (a controversial practice since the number of deaths from gastrointestinal bleeding, stroke and cancer in otherwise healthy men taking daily aspirin outnumber the lives saved by its’ cardiac benefits). Since aspirin may also increase the risk of complications from viral infections, it might be unwise for men taking this drug (or any other anti-inflammatory agent) to be exposed to COVID-19.

Viruses are not “living” organisms, but they are ubiquitous in nature, outnumbering bacteria by 10:1. There are approximately 380 trillion viruses in the average healthy human body (compared with 37 trillion human cells); they are the single most abundant biological agent on the planet with more than 1030 (one nonillion) in the oceans alone and more than 1.7 million different viral species already identified.

Not only do viruses spread through person-to-person contact, but they are readily transported and disseminated through the atmosphere where they remain viable for long periods of time. National border patrols, fences, walls and quarantines cannot interrupt this mode of transmission. More than 800 million viruses fall onto every square meter of ground per-day across the entire globe, even in the most “pristine alpine environments.” In addition to viruses, more than 545 different bacterial and 168 different fungal species are transported in fog, clouds and “fresh air.” The concentration density of these micro-organisms increases as air becomes more polluted with smog, dust and smoke.

Viral exposure is inevitable and exposure to COVID-19 will probably also touch everyone at some point. For most people this will not be a bad thing, particularly since most viruses seem to provide long-term health benefits, but for those suffering from chronic illness and taking medicines that prevent their immune systems from responding appropriately, this could be a devastating illness.

Surviving the challenges posed by the introduction of any new organism (an acute infection) can be asymptomatic (at best) and deadly at worst, but every healthy human carries multiple benign asymptomatic chronic viral infections all the time. Only a very small fraction of these viruses are capable of causing human illness, and most exist in symbiosis with the immune system and the microbiome. These viruses act beneficially to protect against many illnesses, as the herpes simplex virus (HSV) prevents and eliminates late stage malignant melanoma, and many “common cold” viruses prevent and cure bladder, brain, and breast cancers.

Some viruses only become pathogenic (lead to disease) when either the immune system is impaired (by genetics or medications) or the microbiome is disrupted (by the overuse of antibiotics and other drugs): antibiotic induced dysbiosis (ecological imbalances in the form of yeast infections and bacterial overgrowth) triggers the herpes simplex Type II virus to become increasingly lethal, while similar dysbioses trigger the human papillomavirus (HPV) to become invasive and cause cervical cancer. It is important to realize that both of these viruses (and most others) exist in benign symbiosis with the body without causing illness unless they are triggered by immune suppression (drugs or genetics) or microbiome dysbiosis (many drugs).

Many viruses play key roles in immune system development, and their absence can create long-term health problems: the offspring of mothers who have never been exposed (prior to pregnancy) to rubella or coxsackie B viruses, are at significantly higher risk of developing autoimmune diseases, including type 1 diabetes. Mice harboring herpesvirus, cytomegalovirus, or Epstein Barr Virus are protected against bacterial infections caused by Listeria monocytogenes (which causes gastroenteritis and brain infections) and Yersinia pestis (which causes bubonic plague).

Most viruses evolve rapidly and adapt to their hosts, aiming to become less “virulent” and more symbiotic over time. Even the corona virus has demonstrated this ability to mutate and adapt to its environment since it has already created a newer, less aggressive strain in China. This adaption process depends on many factors including the ecology of the microbiome, the health of the host immune system, the treatments that are used to fight it. A virus’s genetic ability to create a “metastatic equilibrium” is what eventually leads to commensalism, symbiosis and mutually assured survival.

Viruses and other infectious organisms tend to become less (not more) virulent over time, unless antibiotics and antiviral medicines are used in treatment. Antibiotic and antiviral resistance are examples of how this approach leads to greater instability in the microbiome and greater susceptibility to infectious organisms.

Viruses (like bacteria and fungi) are essential components of the environment and exist in all living systems. Healthy survival in any ecosystem requires continual exposure and adaptation to the influence and presence of viruses. Conventional medical therapeutics have historically favored antibacterial and antiviral approaches that have ignored the ecological fall-out and disastrous long-term effects on health. Instead of working to promote the integration of these infectious organisms into an ecologically sustainably diverse microbiome, medical treatments most commonly engender heightened ecological dysbiosis, immune system dysfunction, resistant organisms and conditions that set the stage for chronic inflammation, and increased vulnerability to epidemic infectious illness. The effect of the COVID-19 epidemic is an example of the consequences of a short-sighted medical approach propagated over the last two centuries, as it affects the elderly and infirm.

What is most needed at this time is an effective system of medicine that promotes immune system health and microbiome ecology instead of weakening the relationship between these critical organs and promoting antibacterial and antiviral resistance.

Homeopathic medicines have been shown to be effective across a wide range of infectious conditions, both in clinical and pre-clinical (laboratory) settings without damaging the immune system or the microbiome. Ultra-highly diluted homeopathic medicines work by regulating the expression of genetic information at the cellular level. They have been shown to significantly lower the risk of developing infection when used prophylactically before viral exposure. Homeopathy has been shown to be effective in the management of life-threatening sepsis (a systemic infection) when used adjunctively alongside conventional management in the intensive care unit (ICU). Survival benefit is significantly improved acutely and for many months following hospital discharge. Homeopathy has been found to be effective in numerous public health situations treating a range of both infectious , and noninfectious conditions.

Homeopathic medicines demonstrate significant antiviral effects against multiple human pathogenic respiratory viruses in-vitro, altering patterns of both pro- and anti-inflammatory cytokines, suggesting that they may lower the risk of “cytokine storms” while restoring the ecology of the human organism. Homeopathic medicines have been used to treat and prevent epidemic illnesses around the world significantly reducing viral loads, improving lymphocyte counts, and providing physical, neurologic, immunologic benefits along with improved quality of life and increased survival in HIV/AIDs and reducing the occurrence of epidemic Leptospirosis.

The science of understanding viral infections and the human virome is in its infancy, at best, but it is abundantly clear that viral epidemics and pandemics are made worse by practices that weaken, rather than strengthen the immune system-microbiome axis. It is clear that, at least part of the gravity of the COVID-19 epidemic now facing modern society, has been aggravated by modern medical practices which weaken immunity, restrict diversification of the microbiome and overtreat common infections with antibiotics and antivirals. Vaccinations can also be problematic, since they don’t generally promote permanent immunity to infectious agents, and their imperfect effects on immunity may even promote pandemic infections.

Modern medicine has provided many advantages in the world, but there is no sustainable substitute or shortcut if the environmental imperatives of the microbiome are ignored. The homeopathic approach, which supports the immune system-microbiome axis, is critical to maintaining health, particularly during times of epidemic illness.

In terms of a practical approach to COVID-19 it is imperative to recognize the importance of healthy lifestyle and diet in addition to appropriate homeopathic treatment. It is also important to avoid (as much as possible) unnecessary medical therapies that weaken the immune system or damage the microbiome. Avoid immune-suppressing medicines, including prescription or over the counter (OTC) drugs that block inflammation (ibuprofen, aspirin, Tylenol), or damage the microbiome (antibiotics, antivirals) if they are not necessary. Inflammation is the primary defense of the innate immune system, and drugs that interfere with it will impair the body’s ability to fight infection.

At this time, no homeopathic practitioners have treated cases of COVID-19, or made the results of this treatment public. A worldwide network of practitioners, from India, Asia, Europe and the Americas, have been in communication and have been looking to share information on the Genus Epidemicus when it emerges. Since no one has had any direct experience using homeopathy to treat COVID-19 to date, the following seasonal influenza medicines have been highly recommended as fallback for consideration in individual cases, but they are clinically unproven in COVID-19. Each case should be carefully evaluated to determine the most appropriate medicine:

Gelsemium sempervirens, Bryonia alba, Mercurius vivus, Eupatorium perfoliatum, Arsenicum album, and Squilla maritma.

A COVID-19 nosode is not yet available, nor is it expected to be manufactured at any time soon, but evidence from the recent Cuban experience42 suggests that it might prove to be extremely beneficial in this epidemic.

Wash hands and take reasonable precautions to avoid people who may be ill. Do NOT use antibacterial soaps, hand sanitizers, gloves or masks.

Adequate rest and relaxation are critical and should be prioritized. Manage stressful activities and work situations in a timely manner to ensure adequate time for recovery.

Eliminate refined sugars and foods with a high glycemic index from the diet. Discontinue all nonessential vitamin and mineral supplements for the duration of an acute illness. Utilize probiotics and pre-and pro-biotic containing foods (naturally fermented foods and brine). Eat lightly or fast for short periods.

Remember to hydrate adequately but avoid over-hydration. Urine frequency, odor and color can be used to judge hydration status.

Do not try to lower fevers unless this is deemed medically necessary. Postpone showers and baths to avoid becoming chilled.

Stay in contact with your primary care physician. Remember that viral illnesses are normal and that most people who are otherwise healthy will benefit immunologically from these experiences (even though they may be unpleasant). Infections help the immune system manage and reduce chronic inflammation and can provide significant long-term health benefits. Try to avoid using any unnecessary medicines that simply manage symptoms. Consult closely with your homeopath if you are having difficulties or if you seem to be getting worse, rather than better. Pay attention to your instincts and ask for help if things are progressing unexpectedly.

About the Author: Ronald D. Whitmont, MD is Board Certified in Internal Medicine, and Holistic and Integrative Medicine, Clinical Assistant Professor of Family and Community Medicine at New York Medical College, immediate past president of the American Institute of Homeopathy. He maintains a practice of Classical Homeopathic Medicine in Rhinebeck and New York City, NY.